Cargando…
DETC Induces Leishmania Parasite Killing in Human In Vitro and Murine In Vivo Models: A Promising Therapeutic Alternative in Leishmaniasis
BACKGROUND: Chemotherapy remains the primary tool for treatment and control of human leishmaniasis. However, currently available drugs present serious problems regarding side-effects, variable efficacy, and cost. Affordable and less toxic drugs are urgently needed for leishmaniasis. METHODOLOGY/PRIN...
Autores principales: | Khouri, Ricardo, Novais, Fernanda, Santana, Gisélia, de Oliveira, Camila Indiani, Vannier dos Santos, Marcos André, Barral, Aldina, Barral-Netto, Manoel, Van Weyenbergh, Johan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006171/ https://www.ncbi.nlm.nih.gov/pubmed/21200432 http://dx.doi.org/10.1371/journal.pone.0014394 |
Ejemplares similares
-
Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study
por: Van Weyenbergh, Johan, et al.
Publicado: (2004) -
DETC-based bacterial cellulose bio-curatives for topical treatment of cutaneous leishmaniasis
por: Celes, Fabiana S., et al.
Publicado: (2016) -
SOD1 Plasma Level as a Biomarker for Therapeutic Failure in Cutaneous Leishmaniasis
por: Khouri, Ricardo, et al.
Publicado: (2014) -
CD8(+) Granzyme B(+)–Mediated Tissue Injury vs. CD4(+)IFNγ(+)–Mediated Parasite Killing in Human Cutaneous Leishmaniasis
por: Santos, Claire da Silva, et al.
Publicado: (2013) -
Gene Expression Profile of High IFN-γ Producers Stimulated with Leishmania braziliensis Identifies Genes Associated with Cutaneous Leishmaniasis
por: Carneiro, Marcia W., et al.
Publicado: (2016)